Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001399529-21-000201
Filing Date
2021-12-29
Accepted
2021-12-29 16:20:44
Documents
1
Period of Report
2021-12-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164081283175966.html 4  
1 FORM 4 wf-form4_164081283175966.xml 4 25858
  Complete submission text file 0001399529-21-000201.txt   27217
Mailing Address C/O SKYLINE VENTURES 525 UNIVERSITY AVE., SUITE 1350 PALO ALTO CA 94301
Business Address
HOFFMAN STEPHEN J (Reporting) CIK: 0001190418 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36281 | Film No.: 211529101

Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

EIN.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations